Fenwick represented TigerConnect, a healthcare platform used to promote care team collaboration, in its $45 million Series D financing. The financing was led by healthcare-focused investor HealthQuest Capital, with additional investment coming from New Leaf Ventures, Montreux Growth Partners, Norwest Venture Partners, Invus and Industry Ventures.
TigerConnect intends to use the funding to fuel continued investment into its telehealth and workflow collaboration platform to meet surging demand. More information can be obtained from TigerConnect’s announcement.
The Fenwick transaction team was led by corporate partners Michael Esquivel and Ryan Slunaker and associates Adam Derry and Michael Ohta.